FDA 483 - Nagl MedTech - September 20, 2022

Naglreiter Consulting, LLC, a contract manufacturer in Miramar, FL, was cited for multiple quality system deficiencies during an FDA inspection. Observations included inadequate supplier controls, unvalidated manufacturing processes, and failures in design validation and risk analysis documentation. The firm also failed to adequately establish procedures for device history records.